Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shizhen Zhou
Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
OncoTargets and Therapy
Oncology
Pharmacology
MicroRNA‑370 Suppresses the Progression and Proliferation of Human Astrocytoma and Glioblastoma by Negatively Regulating Β‑catenin and Causing Activation of FOXO3a
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Related publications
Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma
New England Journal of Medicine
Medicine
Chemotherapy Plus Concomitant Low-Dose Fractionated Radiotherapy as Second-Line Treatment for Recurrent or Progressive Glioblastoma After Temozolomide-Based Chemoradiation: A Pilot Study.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
ACS Applied Materials & Interfaces
Medicine
Materials Science
Nanotechnology
Nanoscience
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Mycophenolate Mofetil for Myasthenia Gravis: An Open-Label Pilot Study
Neurology
Neurology
Rufinamide for Refractory Focal Seizures: An Open-Label, Multicenter European Study
Seizure : the journal of the British Epilepsy Association
Medicine
Neurology
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
Neurologia Medico-Chirurgica
Surgery
Neurology
Change in Type-2 Biomarkers and Related Cytokines With Prednisolone in Uncontrolled Severe Oral Corticosteroid Dependent Asthmatics: An Interventional Open-Label Study
Thorax
Pulmonary
Respiratory Medicine
